Literature DB >> 27888137

The role of RhoA in retrograde neuronal death and axon regeneration after spinal cord injury.

Jianli Hu1, Guixin Zhang1, William Rodemer1, Li-Qing Jin1, Michael Shifman1, Michael E Selzer2.   

Abstract

Paralysis following spinal cord injury (SCI) is due to interruption of axons and their failure to regenerate. It has been suggested that the small GTPase RhoA may be an intracellular signaling convergence point for several types of growth-inhibiting extracellular molecules. Even if this is true in vitro, it is not clear from studies in mammalian SCI, whether the effects of RhoA manipulations on axon growth in vivo are due to a RhoA-mediated inhibition of true regeneration or only of collateral sprouting from spared axons, since work on SCI generally is performed with partial injury models. RhoA also has been implicated in local neuronal apoptosis after SCI, but whether this reflects an effect on axotomy-induced cell death or an effect on other pathological mechanisms is not known. In order to resolve these ambiguities, we studied the effects of RhoA knockdown in the sea lamprey central nervous system (CNS), where after complete spinal cord transection (TX), robust but incomplete regeneration of large axons belonging to individually identified reticulospinal (RS) neurons occurs, and where some RS neurons show unambiguous delayed retrograde apoptosis after axotomy. RhoA protein was detected in neurons and axons of the lamprey brain and spinal cord, and its expression was increased post-TX. Knockdown of RhoA in vivo by retrogradely-delivered morpholino antisense oligonucleotides (MOs) to the RS neurons significantly reduced retrograde apoptosis signaling in identified RS neurons post-SCI, as indicated by Fluorochrome Labeled Inhibitor of Caspases (FLICA) in brain wholemounts. In individual RS neurons, the reduction of caspase activation by RhoA knockdown began at 2weeks post-TX and was still seen at 8weeks. RhoA knockdown slowed axon retraction and possibly increased early axon regeneration in the proximal stump. The number of axons regenerating beyond the lesion more than 5mm at 10weeks post-TX also was increased. Thus RhoA knockdown both enhanced true axon regeneration and inhibited retrograde apoptosis signaling after SCI.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axon regeneration; FLICA; Lamprey; Neuronal death; RhoA; Spinal cord injury

Mesh:

Substances:

Year:  2016        PMID: 27888137      PMCID: PMC5219843          DOI: 10.1016/j.nbd.2016.11.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  51 in total

1.  The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar.

Authors:  Philippe P Monnier; Ana Sierra; Jan M Schwab; Sigrid Henke-Fahle; Bernhard K Mueller
Journal:  Mol Cell Neurosci       Date:  2003-03       Impact factor: 4.314

2.  Activated caspase detection in living tissue combined with subsequent retrograde labeling, immunohistochemistry or in situ hybridization in whole-mounted lamprey brains.

Authors:  Jianli Hu; Guixin Zhang; Michael E Selzer
Journal:  J Neurosci Methods       Date:  2013-09-08       Impact factor: 2.390

3.  Prolonged lesional expression of RhoA and RhoB following spinal cord injury.

Authors:  Sabine Conrad; Hermann J Schluesener; Katrin Trautmann; Nicolas Joannin; Richard Meyermann; Jan M Schwab
Journal:  J Comp Neurol       Date:  2005-06-27       Impact factor: 3.215

4.  Cell survival or cell death: differential vulnerability of long descending and thoracic propriospinal neurons to low thoracic axotomy in the adult rat.

Authors:  A C Conta Steencken; I Smirnov; D J Stelzner
Journal:  Neuroscience       Date:  2011-05-31       Impact factor: 3.590

5.  Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration.

Authors:  L N Novikova; L N Novikov; J O Kellerth
Journal:  Eur J Neurosci       Date:  2000-02       Impact factor: 3.386

6.  Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors.

Authors:  Daniel Fisher; Bin Xing; John Dill; Hui Li; Hai Hiep Hoang; Zhenze Zhao; Xiao-Li Yang; Robert Bachoo; Stephen Cannon; Frank M Longo; Morgan Sheng; Jerry Silver; Shuxin Li
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

7.  Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord.

Authors:  Philip Duffy; Andre Schmandke; Antonio Schmandke; Jonathan Sigworth; Shuh Narumiya; William B J Cafferty; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

8.  Expression of the repulsive guidance molecule RGM and its receptor neogenin after spinal cord injury in sea lamprey.

Authors:  Michael I Shifman; Rae Eden Yumul; Cindy Laramore; Michael E Selzer
Journal:  Exp Neurol       Date:  2009-03-05       Impact factor: 5.330

9.  IGF-I gene delivery promotes corticospinal neuronal survival but not regeneration after adult CNS injury.

Authors:  Edmund R Hollis; Paul Lu; Armin Blesch; Mark H Tuszynski
Journal:  Exp Neurol       Date:  2008-10-02       Impact factor: 5.330

10.  Selective expression of CSPG receptors PTPσ and LAR in poorly regenerating reticulospinal neurons of lamprey.

Authors:  Guixin Zhang; Jianli Hu; Shuxin Li; Lisa Huang; Michael E Selzer
Journal:  J Comp Neurol       Date:  2014-06-15       Impact factor: 3.215

View more
  23 in total

Review 1.  Therapeutic Potential of Astrocyte Transplantation.

Authors:  Nataly Hastings; Wei-Li Kuan; Andrew Osborne; Mark R N Kotter
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

2.  The Composition and Cellular Sources of CSPGs in the Glial Scar After Spinal Cord Injury in the Lamprey.

Authors:  Guixin Zhang; Li-Qing Jin; William Rodemer; Jianli Hu; Zachary D Root; Daniel M Medeiros; Michael E Selzer
Journal:  Front Mol Neurosci       Date:  2022-06-27       Impact factor: 6.261

Review 3.  Physiological functions of non-apoptotic caspase activity in the nervous system.

Authors:  Emilie Hollville; Mohanish Deshmukh
Journal:  Semin Cell Dev Biol       Date:  2017-12-07       Impact factor: 7.727

4.  RhoA activation in axotomy-induced neuronal death.

Authors:  Guixin Zhang; Jianli Hu; William Rodemer; Shuxin Li; Michael E Selzer
Journal:  Exp Neurol       Date:  2018-04-30       Impact factor: 5.330

5.  Comparison of Myelin-Associated Glycoprotein With Vincristine for Facial Nerve Inhibition After Bilateral Axotomy in a Transgenic Thy1-Gfp Rat Model.

Authors:  S Ahmed Ali; John E Hanks; Aaron W Stebbins; Samantha T Cohen; Daniel A Hunter; Alison K Snyder-Warwick; Susan E Mackinnon; Robbi A Kupfer; Norman D Hogikyan; Eva L Feldman; Michael J Brenner
Journal:  JAMA Facial Plast Surg       Date:  2019-09-01       Impact factor: 4.611

Review 6.  RhoA as a target to promote neuronal survival and axon regeneration.

Authors:  Jianli Hu; Michael E Selzer
Journal:  Neural Regen Res       Date:  2017-04       Impact factor: 5.135

Review 7.  Role of Caspase-8 and Fas in Cell Death After Spinal Cord Injury.

Authors:  Daniel Sobrido-Cameán; Antón Barreiro-Iglesias
Journal:  Front Mol Neurosci       Date:  2018-04-03       Impact factor: 5.639

8.  The Effect of Axon Resealing on Retrograde Neuronal Death after Spinal Cord Injury in Lamprey.

Authors:  Guixin Zhang; William Rodemer; Taemin Lee; Jianli Hu; Michael E Selzer
Journal:  Brain Sci       Date:  2018-04-14

9.  Retrograde Activation of the Extrinsic Apoptotic Pathway in Spinal-Projecting Neurons after a Complete Spinal Cord Injury in Lampreys.

Authors:  Antón Barreiro-Iglesias; Daniel Sobrido-Cameán; Michael I Shifman
Journal:  Biomed Res Int       Date:  2017-11-19       Impact factor: 3.411

10.  Trehalose Augments Neuron Survival and Improves Recovery from Spinal Cord Injury via mTOR-Independent Activation of Autophagy.

Authors:  Kailiang Zhou; Huanwen Chen; Huazi Xu; Xiaofeng Jia
Journal:  Oxid Med Cell Longev       Date:  2021-07-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.